TY - JOUR
T1 - The Role of rituximab for newly diagnosed, refractory or relapsed aggressive B-cell lymphoma in adult patients
AU - Fitzmaurice, Christina
AU - Zinke, Richard
AU - Heraly, Bradley
AU - Kahl, Brad
N1 - Publisher Copyright:
© 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
PY - 2016/12/8
Y1 - 2016/12/8
N2 - This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: The objective of this systematic review was to assess the efficacy (OS, PFS, EFS, RR), safety (rate of cytopenias, transfusions, fever, antibiotic use, infusion reactions, secondary malignancies) and QOL of standard chemotherapy regimens (CHOP and other chemotherapy regimens) with and without rituximab for aggressive B-cell lymphoma in adult patients.
AB - This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: The objective of this systematic review was to assess the efficacy (OS, PFS, EFS, RR), safety (rate of cytopenias, transfusions, fever, antibiotic use, infusion reactions, secondary malignancies) and QOL of standard chemotherapy regimens (CHOP and other chemotherapy regimens) with and without rituximab for aggressive B-cell lymphoma in adult patients.
UR - http://www.scopus.com/inward/record.url?scp=85003671205&partnerID=8YFLogxK
U2 - 10.1002/14651858.CD009347.pub2
DO - 10.1002/14651858.CD009347.pub2
M3 - Article
AN - SCOPUS:85003671205
SN - 1469-493X
VL - 2016
JO - Cochrane Database of Systematic Reviews
JF - Cochrane Database of Systematic Reviews
IS - 12
M1 - CD009347
ER -